
Pharmacists transform health care by offering essential services, tackling the opioid crisis, and adapting to new initiatives for better patient outcomes.

Pharmacists transform health care by offering essential services, tackling the opioid crisis, and adapting to new initiatives for better patient outcomes.

This episode explores important insights on PBM reform and what pharmacies can look out for throughout 2026.

As more prescription drugs move to OTC, the pharmacist’s role in their communities are continuing to shift as well.

In part 2, Alyssa Billingsley, PharmD, explores some of the recent switches that made waves in the US and how they impact pharmacy operations as well as patient outcomes.

Community pharmacies continue to operate in unchartered territory regarding Medicare drug price negotiations as the new IRA statute becomes an unavoidable reality for business operations.

With unprecedented changes to Medicare Part D plans at the top of the year, experts from ASCP help pharmacy businesses understand key provisions under the IRA.

The new provisions would be the first major update to a Medicare Part D statute impacting the pharmacy industry in nearly 20 years.

Buchanan Ingersoll & Rooney’s Dae Lee, PharmD, Esq, CPBS, and Lucas Morgan, Esq, explore the evolving world of PBMs within the supply chain as well as the role of state boards of pharmacy.

In part 2, ASCP’s senior policy expert James Lewis breaks down the MTF system and how it is impacting the thousands of pharmacies that dispense Medicare-covered drugs.

Representatives from the American Society of Consultant Pharmacists joined Drug Topics to discuss the day 1 reality of the Medicare Drug Price Negotiation Program.

President of the Pennsylvania Pharmacists Association, John DeJames, shared his organization’s goals for advancing the pharmacy profession.

To celebrate National Pharmacist Day, regonized every year on January 12, Meagan Brown, PharmD, BCACP, discussed the current state of nationally recognizing pharmacists as clinical providers.

The current understanding regarding artificial intelligence (AI) in pharmacy curricula is necessary to equip future pharmacists with advanced technological knowledge.

Mark Ciarlone, PharmD, business development manager at Liberty Software, discusses pharmacy management systems that drive results.

Outcomes’ Jon Carlson and Nic Bernabe discuss PillCount, Rx30, and the technology making a difference behind community pharmacy counters—among many other pharmacy solutions.

In part 3, Meagan Brown, PharmD, BCACP, explored sentiments of pharmacist’s provider status among other health care professionals.

A group of researchers conducts 3 focus groups centered on community pharmacies in Colorado and Utah and the impact of their closures.

Meagan Brown, PharmD, BCACP, discusses the nuances of pharmacists’ provider status and its evolution within the greater health care community.

This episode explores the unique nuance between striving for goals in the pharmacy profession and focusing on personal growth as a long-term effort.

Meagan Brown, PharmD, BCACP, discusses her career journey in various pharmacy roles during National Pharmacist Day, January 12.

Pharmacists received surveys to quantify their usage of collaborative practice agreements among community pharmacies in Ohio.

From gaps in care to formulary challenges, Susan Thomas, RN, explains how her independent PBM is working with pharmacists to improve women’s health outcomes.

In part 3 of our interview with Susan Thomas, RN, she focused on the pharmacist’s role in her organization’s creation of a newly launched women’s health benefit program.

As social media’s growth seemingly has no end in sight, pharmacists must be conscious of its potential risks and benefits when using these platforms for either personal or professional use.

In this episode, host Taylor Watterson, PharmD, PhD, welcomes Julissa Gomez, a fourth-year pharmacy student at the University of Illinois Chicago Retzky College of Pharmacy.

Discover how pharmacy teams are advancing stewardship, opioid safety, and survey readiness through clinical surveillance, competency-based education, and emerging AI tools that help reduce ADEs and improve patient outcomes.